I understand that, and I even referred to the two other methods in my text.
The point is that the virus acting directly on the cancer cells has always been the main method. Which is, 1. contrary to what the "professor" stated, 2. if the company starts moving away from this point it certainly raises reasonable questions re efficacy. That's all.
GLTA.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 16.21pm 14/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable